Smith & Nephew plc (ADR) (NYSE:SNN)

CAPS Rating: 4 out of 5

The Company is a global business engaged in the development, manufacture and marketing of medical devices in the sectors of orthopaedic reconstruction, orthopaedic trauma and clinical therapies, endoscopy and advanced wound management.


Player Avatar dreamjob (86.26) Submitted: 12/29/2012 8:02:26 PM : Outperform Start Price: $53.65 SNN Score: +2.63

Management at SNN has achieved very strong ROIC and Cash ROIC numbers. Sales, earnings, and book value are all growing at a healthy clip. There are positive, stable, and growing owner earnings and free cash flow. There is also manageable debt here. I believe this is priced slightly below intrinsic value. I also like that this has recently become a 5 Star CAPS stock.

Featured Broker Partners